AGP Executive Report
Last update: 6 hours agoKidney Care Breakthrough: The FDA granted traditional approval to Novartis’ Fabhalta (iptacopan) to slow kidney function decline in adults with primary IgA nephropathy, based on Phase III results showing better eGFR outcomes than placebo and a safety profile that includes a higher risk of serious infections. Air Quality & Public Health: Wildfire smoke is expected to linger around Philadelphia, with New Jersey handing out masks to commuters as conditions hit unhealthy levels. Travel Health Watch: UK health data flags imported infections already topping 1,000 cases this year, including malaria, dengue, chikungunya, Zika, and enteric fever—prompting travelers to plan ahead. Autism Access: EarliPoint Health partnered with Autism Testing 4 Kids to expand nationwide, insurance-friendly autism evaluations and reduce wait times. Gut Health Focus: A dietitian-backed guide highlights practical ways to improve gut health in 30 days, emphasizing fiber and fermented foods. Maternal Mental Health: FDA trials report luvesilocin, a mushroom-derived psychoactive, may rapidly improve postpartum depression and anxiety. Fitness Trend: Experts weigh in on whether fasted workouts help or hurt progress, noting the science is mixed.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
